TickrTrends All fair-value coverage

Medline Inc. (MDLN) fair value analysis

Nasdaq · Updated 2026-09-07

Medline Industries is a healthcare company that manufactures and distributes medical supplies, equipment, and solutions used in hospitals, clinics, long-term care facilities, and other healthcare settings. The company operates globally, serving customers across North America, Europe, Asia, and other international markets.

Valuation status

Awaiting full valuation

MDLN does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under our standards — we require at least six validated trailing price-to-earnings windows before publishing one. TickrTrends re-evaluates every covered stock weekly; a verdict publishes automatically once enough validated history accumulates.

X Reddit StockTwits
Last price
$40.47
Sector
Healthcare
12-month range
$35.75–$45.85

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade
D
Leverage
Moderate
RSI zone
Neutral
52-week position
The lower-middle quarter of its range

What our data shows for MDLN

The exact numbers are one step away

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

What people are saying

Follow the MDLN conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

Frequently asked questions

Is MDLN stock undervalued?

MDLN does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.

What is MDLN's TickrTrends verdict?

MDLN is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.

Is MDLN overbought or oversold?

MDLN's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →